statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	395
IT - Italia	172
SG - Singapore	94
CN - Cina	86
VN - Vietnam	59
DE - Germania	50
BR - Brasile	46
HK - Hong Kong	41
RU - Federazione Russa	40
FR - Francia	28
IE - Irlanda	23
FI - Finlandia	17
BD - Bangladesh	14
GB - Regno Unito	14
IN - India	12
NL - Olanda	11
ZA - Sudafrica	11
AR - Argentina	9
CA - Canada	8
MX - Messico	8
ES - Italia	7
PL - Polonia	7
BO - Bolivia	4
JP - Giappone	4
MA - Marocco	4
PE - Perù	4
UA - Ucraina	4
AT - Austria	3
CL - Cile	3
EC - Ecuador	3
KR - Corea	3
SA - Arabia Saudita	3
SE - Svezia	3
AE - Emirati Arabi Uniti	2
AM - Armenia	2
CZ - Repubblica Ceca	2
ID - Indonesia	2
KE - Kenya	2
OM - Oman	2
PH - Filippine	2
TN - Tunisia	2
TR - Turchia	2
VE - Venezuela	2
AG - Antigua e Barbuda	1
AL - Albania	1
CY - Cipro	1
DK - Danimarca	1
DZ - Algeria	1
GT - Guatemala	1
HU - Ungheria	1
IL - Israele	1
IQ - Iraq	1
JO - Giordania	1
KH - Cambogia	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MY - Malesia	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
PA - Panama	1
PK - Pakistan	1
RO - Romania	1
SV - El Salvador	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UZ - Uzbekistan	1
Totale	1.235

Nome	#
HELPER: UNA PIATTAFORMA BIOINFORMATICA PER LA PERSONALIZZAZIONE DELLE PIPELINE NGS	229
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome	131
Pelvic imbalance and leg length discrepancy in Marfan scoliosis	114
Impediments to Heart Transplantation in Adults With MELASMT-TL1:m.3243A>G Cardiomyopathy	112
Unsupervised Assessment of Coronary Artery Tortuosity Through Hidden Markov Models	95
Macrophages and monocytes: “trojan horses” in covid-19	91
Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience	77
Unambiguous Interpretation of the Pathogenicity of the GLA c.547+3A>G Variant Causing Fabry Disease	76
Oxalic Cardiomyopathy: Could it Influence Treatment Plans in Patients With Primary Hyperoxaluria Type 1?	69
Oral contraception use in BRCA gene mutation carriers: information for counselling in routine clinical practice	67
Four pathogenic variants co-occurring in a MINAS early-onset breast cancer	63
The new 2023 ESC guidelines for the management of cardiomyopathies: a guiding path for cardiologist decisions	61
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study	61
CoroSAM: adaptation of the Segment Anything Model for interactive segmentation in Coronary angiograms	4
Totale	1.250

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	9	0	0	0	0	0	0	0	0	1	3	0	5
2022/2023	92	3	5	2	8	2	6	13	4	31	5	9	4
2023/2024	117	7	9	4	4	12	11	11	16	0	10	13	20
2024/2025	284	15	15	10	4	2	12	35	24	60	21	32	54
2025/2026	718	58	34	70	112	93	28	105	37	61	75	32	13
2026/2027	28	28	0	0	0	0	0	0	0	0	0	0	0
Totale													1.250